TYRAInvestor Events•prnewswire•August 20, 2025 at 08:05 PM

Tyra Biosciences Announces Participation at Upcoming Investor Events

Sentiment:Negative (20)

Summary

CARLSBAD, Calif., Aug. 20, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 20, 2025 by prnewswire